FDA Sued Over Rejection of Supplement Ad Claims

The Alliance for Natural Health USA is suing FDA over the agency’s rejection of 114 health-related advertising claims for dietary supplements. Three Benesch Friedlander Coplan & Aronoff attorneys write in an online post that the Alliance claims that FDA’s interpretation of what counts as an “authoritative statement” unfairly blocks science-backed but not FDA-approved claims from appearing on product labels.

In 2025, the Alliance and three supplement manufacturers asked FDA for permission to include 118 health-related claims on their supplement labels by using the “authoritative statement” pathway rather than the full petition process.

The post says manufacturers are permitted to make health claims based on an “authoritative statement” from a U.S. government scientific body or the National Academy of Sciences. FDA rejected 114 of the proposed labeling claims, noting that although the statute does not define “authoritative,” the agency is using a narrow reading of the term that requires that any health-related claims be grounded in “official” or “consensus” positions.

In its suit, the attorneys write, the Alliance argues that the FDA definition of “authoritative” imposes additional hurdles that the law’s plain language does not support. It says the agency interpretation raises serious 1st Amendment concerns because it imposes a blanket ban on science-backed claims without considering other less-restrictive alternatives.

The complaint asks the court to set aside the FDA denial letter and categorize it as unlawful, and then issue an order allowing the previously rejected health-based claims to be used.

“If successful,” the attorneys conclude, “this lawsuit could reshape how supplement, food, and beverage companies market their health- and nutrition-related products.” They say a successful suit could:

• open the authoritative statement pathway for supplement manufacturers, allowing them to market disease risk reduction claims without the expense and delay of a full petition to FDA;
• lead to broader latitude about qualified health claims on nutrition labels and in marketing materials; and
• have an industry-wide impact by allowing other companies to issue marketing statements concerning verified vitamin, mineral, and botanical ingredients.

“The case’s potential for widespread impact across relevant industries makes it one to watch,” the attorneys say.